<i>PIK3CA</i> and <i>TP53</i> mutations predict overall survival of stage II/III colorectal cancer patients.

World J Gastroenterol · 2018 · PMC5799864 · PMID 29434452

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendP = 0.052so close (0.05 < p ≤ 0.1)

The PIK3CA mutation located in the kinase domain showed a trend toward a shorter OS compared with wild-type tumors (multivariate HR = 1.56; 95%CI: 1.00-2.44; P = 0.052).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.